News

We know you love a good diagnostic challenge. Can you solve these 6 cases that we've featured over the past year?

Switching from adalimumab to etanercept or vice versa after interruption can improve treatment response, data presented in London suggests.

Phase three trials of the selective IL-23 blocker risankizumab are replicating the promising results achieved by phase two trials for psoriasis, researchers report in London.

Secukinumab has been shown to be effective for the treatment of moderate-to-severe plaque psoriasis in hard-to-treat patients who failed anti-TNFa treatment, researchers report in London.

As the field of medicine becomes more complex, so do the legal questions that can mean the difference between a lawsuit with a positive result and one with a negative result. Dr. Goldberg looks at 5 potential situations and offers his advice.

Adding caffeine to topical skin treatments would be a simple way to reduce inflammation in patients with atopic dermatitis and psoriasis, suggests a review presented at the Psoriasis: From Gene to Clinic International Congress, which took place in London this week.

Dr. Nice performed a series of IPL procedures on a male patient for facial redness. With each subsequent treatment, the patient became increasingly unhappy and belligerent. The patient demanded a refund saying Dr. Nice's family and staff would regret it if one was not provided. What can he do?

The purpose of a budget is to help a practice spend less than what it earns. Benchmarking indicates whether a practice is underachieving or overachieving compared to similar businesses. Learn more.

Cosmetic safety is very important since these products are used by millions of people worldwide. Think of all the cosmetic products in your bathroom and how many of them have caused problems through years of repeated use.

Another way cosmetics insure their safety is by adhering to a list of substances known as GRAS ingredients. GRAS stands for “Generally Recognized as Safe” and indicates ingredients that are currently widely used in the marketplace without safety issues.

Cleansers are routinely tested prior to commercial release for mildness with the Forearm Controlled Application Technique (FCAT).

The December issue of Dermatology Times highlights expected biologic developments to watch for in 2018, aesthetic technique pearls, and the basics of managing your dermatology practice, including budgeting, social media ethics and the legalities surrounding telemedicine.

From biopsy codes used to remove hematomas to codes used for pathology charges, ICD-10 isn’t always straightforward. Reference our table for helpful tips from Karl Ellzey.

Lasers and photodynamic therapy are practical treatment options for acne patients who fail or aren’t compliant with traditional first-line therapies. Today’s energy devices might also enhance acne treatment as adjuvant therapy, a review shows.

Dermatologists and others are increasingly using lasers and light-based therapies to treat acne, but the literature proving efficacy among these therapies is limited by few high-powered trials and lots of small, low-quality studies.

A practice with disengaged employees risks bleeding cash, says Amy Koon of the medical practice management firm Keystone Medical. In this article, Ms. Koon highlights key steps necessary for creating employee engagement.

Experts from around the world will gather in London at the Psoriasis from Gene to Clinic Congress to present and discuss the most current developments in the understanding of psoriasis and the evidence that will steer future clinical decision making. Watch here for highlights.

Patients with psoriasis are more likely than the general population to receive a diagnosis of malignant lymphoma. Why? Cutaneous T-cell lymphoma is misdiagnosed as psoriasis and can also be mistaken for atopic dermatitis due to similarities in the skin manifestation.

Healthcare is being delivered in a different environment from that of our predecessors, Dr. Wheeland says. Is it still possible for the solo dermatologist to succeed?

The latest roundup of new dermatology products includes safe ultrasound treatment in the home, skincare for aging skin, and topical pain relief.

In this slideshow, we summarize the phenotypes associated with childhood atopic dermatitis as addressed recently in JAMA Pediatrics.

Choosing technologies for noninvasive body contouring depends on what areas they are approved to treat, the local competition and - where available - the data, say experts.

Choosing between a needle or cannula for filler injections is largely a matter of individual preference, said live-injection experts at The Cosmetic Bootcamp (CBC) 2017. For safety and accuracy of filler placement, they chose cannulas for filling the lips, hands and periocular area.

The American College of Rheumatology annual meeting wrapped this month in San Diego. Results from long-awaited safety trials show promising new treatments.

It's that time of year when we sit back and reflect on where we are and where we've come. When you look around you at the office or at home, what are the things and who are the people that you truly appreciate? Here at Dermatology Times, we look around and feel so grateful for all of you who put your trust in us every day! If it weren't for you, there wouldn't be an "us". Happy Thanksgiving from us to you!

Until recently, atopic dermatitis treatments were primarily limited to topical corticosteroids and systemic immunosuppressants. Now, two new therapies have reached clinical practice. Nineteen more are in development.

Annual employee performance reviews rank near the top of least favorite tasks for most physicians and their staff. Here are 6 questions to ask your employees to get the most out of the review process.

In this slideshow, we highlight recently published research findings on newly identified genetic mutations associated with conjunctival melanoma, expanding the definition of melanoma to include population diversities, and dermatomyositis that fails treatment.

Patients with vascular anomalies benefit from multidisciplinary treatment often involving propranolol and/or sirolimus.

mTOR inhibitor helps child with diffuse vascular anomalies and extensive organ involvement.